प्रौद्योगिकी प्रस्ताव

• CSIR-NCL process is rapid, scalable, tunable & continuous and hence, no batch consistency issue
  
• The developed process is continuous and can be demonstrated at 1 kg/day scale (TRL-4)
  

अनुप्रयोग

• Drug delivery
• Support material to make chromatographic media
• Solubility enhancer in pharmaceutical formulations
• Imaging & diagnostic agent
• Catalysis (Largest application)
• Enzyme immobilization (bio-catalysis)
• Direct air capture of CO₂

वर्तमान स्थिती

• The process is demonstrated at 1 kg/day scale with a fully automatic pilot plant
• Available for licensing/co-development (TRL-4)

मूल्य प्रस्ताव

• Monodispersed product
• Continuous & scalable process
• Shorter reaction times (20-30 minutes)
• Clogging-free process: Smart composition selection
• Tunable process to make monodisperse MSNs (controllable particle size)
• Unreacted material is recycled, resulting in zero discharge

विशेषताएँ

Product specifications:

• Form: Powder
• Particle size (nm): 50, 100, 250, 500, 1500
• Surface area: > 771 m²/g
• Pore Dia: 2-4 nm
• Pore volume: > 0.467 cc/g

अन्य सूचना

बाज़ार संभाव्यता

• The Mesoporous Silica Market size is estimated at USD 188.67 Million in 2025, and is expected to reach USD 299.32 Million by 2030, at a CAGR of 9.67% during the forecast period (2025-2030).
• North America has the largest market in 2024 at 35%. 
• Asia-Pacific registers the fastest CAGR of 9.88% through 2030, with pharmaceutical and biotechnology fields.

पृष्ठभूमि

• Mesoporous and nanoporous silica particles have porosity in the range of a few nm to a few µm. Well-known commercial grades are MCM-41 & SBA-15.
• MSNs with high porosity and surface area are biocompatible and non-toxic.
• Conventional batch processes require meticulous parameter control through the gradual addition of reagents.
• Typical batch times range from hours to a few days due to slow reactions.

नवप्रवर्तक और उत्पाद

उपयोगी संदर्भ